Search research articles
Contact Us
Filters
Showing results (71-80 of 107) with videos related to
Page
of 11
Sort By:
Journal of Cancer
|
March 26, 2014
Partial Response at Completion of Bortezomib-Thalidomide-Dexamethasone (VTd) Induction Regimen Upfront in Multiple Myeloma Does Not Preclude Response to VTd in Consolidation
Guillemette Fouquet, Benjamin Hebraud, Sylvain Garciaz, et al.
Cancer Medicine
|
March 15, 2025
Real-World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated Before the Era of Anti-CD38 Antibodies: The EMMY Cohort From 2017 to 2020
Laure Vincent, Olivier Decaux, Aurore Perrot, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 17, 2025
The Impact of Anti-CD38 Monoclonal Antibodies in Frontline Therapy for Patients With Newly Diagnosed Multiple Myeloma: Real-Life Results From the EMMY Study
Thomas Chalopin, Olivier Decaux, Cyrille Hulin, et al.
British Journal of Haematology
|
March 28, 2023
Pomalidomide and dexamethasone until progression after first salvage therapy in multiple myeloma
Laurent Garderet, Frederique Kuhnowski, Benoit Berge, et al.
Blood
|
August 12, 2011
Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program
Mehdi Khellaf, Marc Michel, Philippe Quittet, et al.
Leukemia
|
September 15, 2025
Molecular profiling and risk stratification in solitary bone plasmacytoma
Barbara Burroni, Stéphanie Harel, Raphaele Seror, et al.
Blood
|
September 3, 2021
Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experience
Alexis Caulier, Murielle Roussel, Pierre Morel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2019
Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma
Aurore Perrot, Valérie Lauwers-Cances, Elodie Tournay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2016
Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial
Cyrille Hulin, Andrew Belch, Chaim Shustik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2013
The translocation t(4;14) can be present only in minor subclones in multiple myeloma
Benjamin Hébraud, Denis Caillot, Jill Corre, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 107) with videos related to
Sort By:
Page
of 11
Journal of Cancer
|
March 26, 2014
Partial Response at Completion of Bortezomib-Thalidomide-Dexamethasone (VTd) Induction Regimen Upfront in Multiple Myeloma Does Not Preclude Response to VTd in Consolidation
Guillemette Fouquet, Benjamin Hebraud, Sylvain Garciaz, et al.
Cancer Medicine
|
March 15, 2025
Real-World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated Before the Era of Anti-CD38 Antibodies: The EMMY Cohort From 2017 to 2020
Laure Vincent, Olivier Decaux, Aurore Perrot, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 17, 2025
The Impact of Anti-CD38 Monoclonal Antibodies in Frontline Therapy for Patients With Newly Diagnosed Multiple Myeloma: Real-Life Results From the EMMY Study
Thomas Chalopin, Olivier Decaux, Cyrille Hulin, et al.
British Journal of Haematology
|
March 28, 2023
Pomalidomide and dexamethasone until progression after first salvage therapy in multiple myeloma
Laurent Garderet, Frederique Kuhnowski, Benoit Berge, et al.
Blood
|
August 12, 2011
Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program
Mehdi Khellaf, Marc Michel, Philippe Quittet, et al.
Leukemia
|
September 15, 2025
Molecular profiling and risk stratification in solitary bone plasmacytoma
Barbara Burroni, Stéphanie Harel, Raphaele Seror, et al.
Blood
|
September 3, 2021
Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experience
Alexis Caulier, Murielle Roussel, Pierre Morel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2019
Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma
Aurore Perrot, Valérie Lauwers-Cances, Elodie Tournay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2016
Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial
Cyrille Hulin, Andrew Belch, Chaim Shustik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2013
The translocation t(4;14) can be present only in minor subclones in multiple myeloma
Benjamin Hébraud, Denis Caillot, Jill Corre, et al.
Page
of 11